For UK healthcare professionals
ChondroFiller® liquid: product, technique, evidence and UK supply.
A cell-free, two-component type I collagen matrix of animal origin (rat tail tendon), as described in the published literature, supplied as a collagen solution and a neutralising solution that are mixed through an adapter at the point of use and form a stable gel in the prepared defect within minutes. Supplied in the UK, with training and support, by Actomed.

At a glance
Composition, presentation and regulatory status.
- Composition
- Type I collagen matrix, animal origin (rat tail tendon); cell-free, two-component1
- Presentation
- Dual-chamber syringe: collagen and neutralising solutions, mixed through an adapter at the point of use2
- Formats
- 1.0 ml, 1.5 ml, 2.3 ml2
- Setting time
- Approximately 3 to 5 minutes2
- Regulatory status
- Listed on the MHRA register of medical devices. Registration is not approval.
- Collagen concentration
- 8 mg per ml, type I, in buffer3
In this section
Product, technique, rehabilitation, evidence, resources and supply.
Product information
Composition, indications, contraindications, handling and storage.
OpenSurgical technique
Nine steps from confirming the indication to closure, with the handling window.
OpenRehabilitation
Phased load, mobilisation and activity tables for femoral, patellofemoral, talar and hip defects.
OpenEvidence
Published references and manufacturer documents, with study design and follow-up.
OpenResources
Every document with a cover and a direct link, the hosted papers and the animation.
OpenProfessional FAQ
Short, sourced answers to what clinics ask before a first case.
OpenTraining and ordering
How UK clinics order ChondroFiller and arrange training.
OpenIFU
How to request the current instructions for use.
OpenReporting
How to report an adverse event or product complaint.
Open
Technique
Thawed, warmed, applied in one pass, set in minutes.
The manufacturer’s surgical technique guide, condensed into nine sourced steps with the handling window that governs the case.
Adverse events and product complaints
References
- 1.Perez-Carro L, Mendoza Alejo PR, Gutierrez Castanedo G, Menendez Solana G, Fernandez Divar JA, Galindo Rubin P, Alfonso Fernandez A. Hip Chondral Defects: Arthroscopic Treatment With the Needle and Curette Technique and ChondroFiller. Arthroscopy Techniques, 10(7):e1669-e1675, 2021. View DOI
- 2.Meidrix Biomedicals GmbH. ChondroFiller® liquid overview brochure. Manufacturer publication, 2024. View source
- 3.Meidrix Biomedicals GmbH. ChondroFiller® liquid surgical technique. Manufacturer publication, 2022. View source